Signals flagged in the original
Analyzed by our bias model Full breakdown ↓
The FDA is continuing its investigation into a botulism outbreak in infants linked to contaminated formula from ByHeart. The agency has not yet identified the source of the contamination or how to prevent it in the future, while companies involved have not taken responsibility.
Our neutral summary
The FDA is continuing its investigation into a botulism outbreak in infants linked to contaminated formula from ByHeart. The agency has not yet identified the source of the contamination or how to prevent it in the future, while companies involved have not taken responsibility.
The reporting belongs to Ars Technica; we don't reproduce it.
No note attached
on this article.
Baby botulism outbreak: FDA still doesn't know cause—or how to prevent it
FDA Investigates Baby Botulism Outbreak Linked to Contaminated Formula